NeoGenomics Inc. Common Stock vs Rackspace Technology Inc. Common Stock — how do they compare? NeoGenomics Inc. Common Stock trades at $16.85 (market cap $2.14B), while Rackspace Technology Inc. Common Stock trades at $3.11 (market cap $925.19M). The key difference: NeoGenomics Inc. Common Stock is far larger — about 2.3× Rackspace Technology Inc. Common Stock's market cap, and NeoGenomics Inc. Common Stock is trading nearer its 52-week high, Rackspace Technology Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold NeoGenomics Inc. Common Stock for 0 Days and Rackspace Technology Inc. Common Stock for 0 Days on average.
| NEO | RXT | |
|---|---|---|
Market Cap | $2.14B | $925.19M |
Volume | 2,228,400 | 2,631,364 |
Sector | Health | Technology |
52-Week High | $19.91 | $7.53 |
52-Week Low | $7.19 | $0.41 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $2.44B | $4.09B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
NeoGenomics, Inc. is a US cancer diagnostics company that provides genomic and pathology testing services, offering an oncology-focused testing menu used by oncologists, pathologists, and hospital systems across the cancer care continuum.
Read more on NEO →Rackspace Technology, Inc. provides managed multicloud and hybrid cloud services, helping organizations design, operate, and support workloads across AWS, Microsoft Azure, Google Cloud, and private infrastructure.
Read more on RXT →